Schizoaffective Disorders Completed Phase 2 Trials for Estradiol (DB00783)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00206570Clinical Estradiol Trial in Women With SchizophreniaTreatment
NCT00206557The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot StudyTreatment
NCT00357006A Definitive Estrogen Patch Study (ADEPT)Treatment